Form4insider filings, from the source

SEC Form 4 · accession 0001366268-26-000004

Inhibrx Biosciences, Inc. · INBX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Sep 8, 2026
Accepted (ET)
Sep 8, 2026 · 5:23 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002007919

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Sep 8, 2026P5,000$113.516A424,360IBy The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
Common StockF3holding———250,000IBy Jon Faiz Kayyem Revocable Trust
Common StockF4holding———250,000IBy Paige Gates-Kayyem Revocable Trust
Common StockF5holding———69,843IBy Child A
Common StockF6holding———69,843IBy Child B

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses